The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026 The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals has informed the BSE that its Board meeting, originally scheduled for 23 February 2026, has been rescheduled to 13 February 2026. The meeting will be held at the company's registered office in Hyderabad. The Board will consider the unaudited financial results for the quarter and nine months ended 31 December 2025, along with the Limited Review Report for the same period. Any other business with the Chair's permission may also be taken up. This is a routine advance intimation under SEBI Listing Regulations.
No direct impact on shareholders; the earlier meeting date simply means Q3 FY26 results will be announced sooner than originally planned. Investors should watch for the results disclosure around 13 February 2026.